Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine
about
Antiviral perspectives for chikungunya virusA Susceptible Mouse Model for Zika Virus InfectionThe role of innate versus adaptive immune responses in a mouse model of O'nyong-nyong virus infectionExtended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine CandidateDNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in miceExposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacyPrime-boost immunization strategies against Chikungunya virusChikungunya vaccines in developmentEvaluation of Commercially Available Chikungunya Virus Immunoglobulin M Detection AssaysThe re-emerging arboviral threat: Hidden enemiesMutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine DesignDevelopment of Vaccines for Chikungunya Fever.A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice.Effective chikungunya virus-like particle vaccine produced in insect cells.Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.A chimeric vesiculo/alphavirus is an effective alphavirus vaccineDeciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.Animal Models of Zika Virus.How Chikungunya Virus Virology Affects Its Epidemiology and Transmission: Implications for Influencing Public Health.O'nyong-nyong fever: a neglected mosquito-borne viral disease.Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus.Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community.Chikungunya Virus Strains Show Lineage-Specific Variations in Virulence and Cross-Protective Ability in Murine and Nonhuman Primate Models.Cellular and Molecular Immune Response to Chikungunya Virus Infection
P2860
Q21284682-D735EC38-439F-435F-A0D9-A3D506B991FAQ24261180-22d848f9-409e-fe0d-4e1e-18a688aebd81Q24276417-499C77E3-255C-492B-96A6-0B93BB1D48F5Q24276430-0E59BFDB-8D9D-4819-B8F8-6B560E6E2154Q24701765-E0B42386-ABCB-4BF8-88B3-ADE133BD2EF3Q24701766-4A5DA05E-CE8E-4678-B562-9DF546376481Q24701774-AC134A5A-2C18-4C11-8A2E-67663CA57198Q26700081-86898FC1-19D4-47BC-A51E-4BB2E7001A8DQ26700135-27E8DFCF-8186-44D1-AA0C-104D19C193AFQ28114692-DAD522E8-8F36-4F20-BACD-939E446C8BE5Q29365400-642FA776-E9AE-453F-927F-EFBBCA3DE527Q30240191-FD8AD375-05BB-4709-A968-F6F806A45FE7Q33945612-8E289B10-BEC3-45DE-A498-F854B8F430F2Q34630576-7DC5CACA-7FC5-45AA-8472-ABECFE06744EQ36318652-92B4E68E-4F1B-4469-8D9D-AED04058EEDBQ36506753-466E679A-A1A3-48AC-82A9-4E2C5EA28AF9Q37065242-E99BE399-53AE-478C-969B-49945804D717Q37643733-81B0F712-73D5-4346-9DF6-41EABC6FDE32Q38158325-829376A6-C7B4-4494-A498-D620A0D1203EQ38786827-3FD99657-F458-45C0-8795-F94186CD9891Q38849136-F16A6070-3F4D-46FE-8D54-214738D8DC63Q40077669-B18A36BB-15ED-4217-9EE0-BA38DD44DB7FQ48095971-C4293917-A4FA-44BA-BA47-14A41B04DC59Q52671193-591359D8-8EC0-42CD-9DB1-51E8B507A818Q58575620-3404BCD9-354C-42E2-9AD4-6494E84A5CA8
P2860
Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Cross-protective immunity agai ...... ecombinant chikungunya vaccine
@ast
Cross-protective immunity agai ...... ecombinant chikungunya vaccine
@en
Cross-protective immunity agai ...... ecombinant chikungunya vaccine
@en-gb
Cross-protective immunity agai ...... ecombinant chikungunya vaccine
@nl
type
label
Cross-protective immunity agai ...... ecombinant chikungunya vaccine
@ast
Cross-protective immunity agai ...... ecombinant chikungunya vaccine
@en
Cross-protective immunity agai ...... ecombinant chikungunya vaccine
@en-gb
Cross-protective immunity agai ...... ecombinant chikungunya vaccine
@nl
prefLabel
Cross-protective immunity agai ...... ecombinant chikungunya vaccine
@ast
Cross-protective immunity agai ...... ecombinant chikungunya vaccine
@en
Cross-protective immunity agai ...... ecombinant chikungunya vaccine
@en-gb
Cross-protective immunity agai ...... ecombinant chikungunya vaccine
@nl
P2093
P2860
P50
P3181
P1433
P1476
Cross-protective immunity agai ...... ecombinant chikungunya vaccine
@en
P2093
Charalambos D Partidos
Erin M Borland
Joanna Paykel
Robert Seymour
P2860
P304
P3181
P356
10.1016/J.VACCINE.2012.04.099
P407
P577
2012-06-29T00:00:00Z